NEW YORK (GenomeWeb News) – Stratagene said today that it has formed a joint development and license agreement with Rosetta Inpharmatics to create automated solution for the isolation of nucleic acids from clinical samples.

Under the deal, the companies will jointly develop an instrument and a single-use consumable, which will be manufactured Stratagene for sale to its customers engaged in pharmacogenomics.

Additional terms of the agreement were not disclosed.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

In an against-all-odds twist, a researcher studying exceeding rare FOXG1 mutations discovers her daughter has the syndrome.

An effort by Genomics Medicine Ireland is creating a database of diseases based on the genomics of people in Ireland. It now is looking into the possibility of including Scotland in its work.

In recent weeks, the direct-to-consumer genetics firm has rolled out a health hub where customers can share information concerning 18 common health conditions.

In PLOS this week, new genes associated with prostate cancer risk, genetic patterns in M. bovis, and more.